| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nccn guidelines hodgkin lymphoma 2023 | 0.65 | 0.5 | 1189 | 67 | 37 |
| nccn | 0.09 | 0.3 | 3009 | 59 | 4 |
| guidelines | 0.31 | 0.8 | 2508 | 8 | 10 |
| hodgkin | 0.19 | 0.3 | 837 | 14 | 7 |
| lymphoma | 1.32 | 0.3 | 3228 | 46 | 8 |
| 2023 | 1.8 | 0.2 | 8255 | 2 | 4 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nccn guidelines hodgkin lymphoma 2023 | 1.43 | 0.4 | 7498 | 39 |
| nccn guidelines hodgkin lymphoma 2022 | 0.16 | 0.4 | 2002 | 73 |
| nccn guidelines hodgkin lymphoma 2020 | 0.37 | 1 | 7125 | 10 |
| nccn guidelines follicular lymphoma 2023 | 0.45 | 1 | 3417 | 8 |
| nccn guidelines hodgkin lymphoma | 0.23 | 1 | 2207 | 26 |
| nccn guidelines 2022 lymphoma | 1.2 | 0.2 | 8203 | 54 |
| nccn guidelines mantle cell lymphoma 2023 | 1.53 | 0.5 | 3232 | 28 |
| nccn b-cell lymphoma guidelines 2022 | 0.96 | 0.4 | 9393 | 24 |
| nccn guidelines cll 2023 | 0.27 | 0.7 | 3914 | 37 |
| t-cell lymphomas nccn 2023 | 0.66 | 0.7 | 7602 | 36 |
| nccn guidelines follicular lymphoma 2022 | 0.53 | 0.8 | 2150 | 70 |
| nccn guidelines 2023 for patients | 0.12 | 0.4 | 1247 | 7 |
| nccn guidelines 2023 cml | 0.01 | 0.4 | 43 | 46 |
| nccn guidelines cns lymphoma | 0.44 | 0.4 | 7758 | 52 |
| nccn guidelines thyroid cancer 2023 | 0.35 | 0.6 | 91 | 20 |
| nccn b cell lymphoma guidelines | 0.39 | 0.5 | 7662 | 25 |
| nccn guidelines 2023 melanoma | 0.51 | 0.3 | 5862 | 26 |
| nccn guidelines 2023 myeloma | 1.63 | 0.9 | 8271 | 55 |
| nccn guidelines for 2023 | 0.27 | 0.3 | 3461 | 29 |
| nccn treatment guidelines 2023 | 1.83 | 0.2 | 4622 | 81 |
